Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dienogest dose-comparison trial in endometriosis-related dysmenorrhea
jRCTs041210016Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dienogest in endometriosis and dysmenorrhea (2 arms), sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoint: Change in visual analog scale score at 48 weeks from baseline. Started Aug 2021; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosisdysmenorrhea
Beyond the preview
Go deeper on jRCTs041210016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210016.